The global lung cancer drug market grows to $59.5B by 2031 as immunotherapy, diagnostics, and policy support fuel rapid expansion. https://www.einpresswire.com/article/816442877/lung-cancer-therapeutics-market-accelerates-amid-innovation-policy-support-and-r-d-deals-datam-intelligence